The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXPD.L Regulatory News (XPD)

  • There is currently no data for XPD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 May 2019 07:00

RNS Number : 1042Y
Xpediator PLC
07 May 2019
 

7 May 2019

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

XPEDIATOR PLC

("Xpediator" or "the Company" or "the Group")

Director/PDMR Shareholding

Xpediator, (AIM: XPD), a leading provider of freight management services across the UK and Europe, announces that on 3 May 2019, the wife and four adult children of Stephen Blyth (Chief Executive Officer of Xpediator), have in total purchased 500,000 shares of 5 pence each in the Company ("Ordinary Shares") at a price of 48 pence per share.

Cogels Investments Limited, a company owned and controlled by the wife and four adult children of Stephen Blyth, already holds a beneficial interest in 34,840,000 Ordinary Shares representing approximately 26.1% of the Company's issued share capital.

Following this transaction therefore, Stephen Blyth and members of his family together hold a direct and indirect beneficial interest in 35,340,000 Ordinary Shares representing approximately 26.4 per cent. of the Company's issued share capital. In addition, Stephen Blyth has a beneficial interest in 857,143 share options.

Enquiries

Xpediator plc

Tel: +44 (0)330 043 2395

Stephen Blyth, Chief Executive Officer

Email: info@xpediator.com

 

 

 

 

SP Angel Corporate Finance LLP (Nominated Advisor & Joint Broker)

Tel: +44 (0)20 3470 0470

Jeff Keating

 

Caroline Rowe

 

 

Cantor Fitzgerald Europe (Joint Broker)

Tel: +44 (0)20 7894 7000

David Foreman, Michael Boot (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

Novella Communications (Financial Public Relations)

Tel: +44 (0)20 3151 7008

Tim Robertson

 

Fergus Young

 

 

About Xpediator:

Xpediator is a well-established international provider of freight management services. Established in 1988 by CEO Stephen Blyth today the Group's International network of offices provides road, sea and air freight services, together with logistics and warehousing in the UK and Romania. The business offers integrated freight management within the supply chain logistics and fulfilment sector, through their three main areas: freight forwarding, logistics & warehousing and transport services. With headquarters in Braintree, Essex and country offices in nine CEE countries across 31 sites, the Group currently employs 938 people and was successfully listed on London's AIM market in August 2017.

For more information, please visit: www.xpediator.com.

Alternatively, do follow us on Twitter at @Xpediator or find us on LinkedIn at Xpediator Plc.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1 1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

A: Lucia Blyth

B: Olivia Blyth

C: Claudia Blyth

D: George Blyth

E: Emilia Blyth

1.2 2.

Reason for the notification

a)

Position/status:

All persons closely associated with PDMR Stephen Blyth, Chief Executive

b)

Initial notification/Amendment:

Initial notification

1.3 3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Xpediator Plc

b)

LEI:

213800XBOVDBT2HEC967

1.4 4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 5p each

 

GB00BF6P5V92

b)

Nature of the transaction:

Purchases of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

a) 48 pence

b) 48 pence

c) 48 pence

d) 48 pence

e) 48 pence

100,000

100,000

100,000

100,000

100,000

d)

Aggregated information:

Aggregated volume:

Price:

 

Price(s)

Volume(s)

 48 pence

500,000

e)

Date of the transaction:

 

3 May 2019

 

f)

Place of the transaction:

AIM, London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAESSEEDNEFF
Date   Source Headline
4th Jan 20236:20 pmRNSForm 8.3 - Xpediator plc
4th Jan 20233:14 pmRNSForm 8 (OPD) - Xpediator plc
21st Dec 202210:29 amRNSForm 8.3 - Xpediator plc
20th Dec 202211:05 amRNSSecond Price Monitoring Extn
20th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20229:41 amRNSForm 8.3 - Xpediator plc
20th Dec 20227:00 amRNSAnnouncement regarding possible offer
3rd Nov 20227:00 amRNSQ3 Trading Update
27th Sep 20229:05 amRNSSecond Price Monitoring Extn
27th Sep 20229:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSHalf-year Report
20th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
10th Jun 202212:56 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
1st Jun 20227:00 amRNSBoard updates
17th May 20228:15 amRNSNotice of AGM
17th May 20227:00 amRNSDirectorate Change
4th Apr 20227:00 amRNSFinal Results
28th Mar 20227:00 amRNSNotice of Results
25th Mar 20224:17 pmRNSDirectorate Change
31st Jan 20227:00 amRNSTrading Update
19th Jan 20227:00 amRNSChange of Adviser
17th Jan 20227:00 amRNSNew Warehouse
22nd Nov 20211:00 pmRNSDirectorate Change
13th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSNotice of Results
6th Aug 20217:00 amRNSStrategic Partnership
6th Jul 20217:00 amRNSExercise of Warrants
25th Jun 20217:00 amRNSTrading Statement
8th Jun 20213:30 pmRNSResult of AGM
8th Jun 20217:00 amRNSAGM Statement
25th May 20217:00 amRNSUpdated Ex-Dividend and Record Dates
12th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20217:00 amRNSFinal Results
7th Apr 20217:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 202111:05 amRNSSecond Price Monitoring Extn
19th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSLaunch of CSOP and Issue of awards to Director
29th Jan 202111:06 amRNSSecond Price Monitoring Extn
29th Jan 202111:00 amRNSPrice Monitoring Extension
29th Jan 20217:00 amRNSTrading Statement
19th Jan 20217:00 amRNSDirectorate Change
31st Dec 20207:00 amRNSDisposal
1st Dec 20207:00 amRNSInvestor Presentation
23rd Nov 20207:00 amRNSTrading Statement
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
6th Oct 20207:00 amRNSAcquisition
1st Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.